BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Arora R, Martin MT, Boike J, Patel S. Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment. World J Hepatol 2023; 15(2): 318-320 [PMID: 36926235 DOI: 10.4254/wjh.v15.i2.318]
URL: https://www.wjgnet.com/1948-5182/full/v15/i2/318.htm
Number Citing Articles
1
Nicola Schiano Moriello, Biagio Pinchera, Ivan Gentile. Personalized care approaches to hepatitis C therapy: recent advances and future directionsExpert Review of Anti-infective Therapy 2024; 22(4): 139 doi: 10.1080/14787210.2024.2328336
2
Alina Maria Constantinescu, Ramona Nicoleta Suciu, Antal Ioan Andrei, Harrie Toms John, Anca Ferician, Nicoleta Negrut, Felicia Manole. Evaluating the Hematological Parameter Alterations Induced by Mavyret in Chronic Hepatitis PatientsGastrointestinal Disorders 2024; 6(4): 832 doi: 10.3390/gidisord6040058